Globus Medical Stock Performance
GMED Stock | USD 84.49 0.23 0.27% |
On a scale of 0 to 100, Globus Medical holds a performance score of 13. The company retains a Market Volatility (i.e., Beta) of 1.15, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Globus Medical will likely underperform. Please check Globus Medical's semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Globus Medical's current trending patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Globus Medical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Globus Medical exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.02) | Five Day Return 1.11 | Year To Date Return 58.91 | Ten Year Return 260.08 | All Time Return 525.74 |
1 | Acquisition by Kelly Huller of 40000 shares of Globus Medical at 53.75 subject to Rule 16b-3 | 09/20/2024 |
2 | Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting | 10/18/2024 |
3 | Globus Medical, Inc. Is Being Investigated For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm | 10/30/2024 |
4 | Earnings call Globus Medical reports robust Q3 growth, eyes 2025 prospects | 11/06/2024 |
5 | GMED or SONVY Which Is the Better Value Stock Right Now | 11/12/2024 |
6 | Q2 2025 Globus Spirits Ltd Earnings Call Transcript | 11/13/2024 |
7 | Why Globus Medical is a Top Value Stock for the Long-Term | 11/14/2024 |
8 | Experian zhlt laut Fortune und Great Place to Work zu den Worlds Best Workplaces 2024 | 11/15/2024 |
9 | Globus Spirits Limiteds Popularity With Investors Under Threat As Stock Sinks 25 | 11/19/2024 |
10 | Stryker Stock May Gain From Oculan Lighting Platforms Launch | 11/20/2024 |
11 | Investors Will Want Globus Maritimes Growth In ROCE To Persist | 11/21/2024 |
12 | Globus Medical, Inc. Hit a 52 Week High, Can the Run Continue | 11/22/2024 |
13 | Globus Medicals SWOT analysis stock soars on merger synergies, FDA hurdles loom | 11/25/2024 |
Begin Period Cash Flow | 150.5 M |
Globus |
Globus Medical Relative Risk vs. Return Landscape
If you would invest 7,136 in Globus Medical on August 28, 2024 and sell it today you would earn a total of 1,313 from holding Globus Medical or generate 18.4% return on investment over 90 days. Globus Medical is currently generating 0.2767% in daily expected returns and assumes 1.6174% risk (volatility on return distribution) over the 90 days horizon. In different words, 14% of stocks are less volatile than Globus, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Globus Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Globus Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Globus Medical, and traders can use it to determine the average amount a Globus Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1711
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | GMED | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.62 actual daily | 14 86% of assets are more volatile |
Expected Return
0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Globus Medical is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Globus Medical by adding it to a well-diversified portfolio.
Globus Medical Fundamentals Growth
Globus Stock prices reflect investors' perceptions of the future prospects and financial health of Globus Medical, and Globus Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Globus Stock performance.
Return On Equity | 0.0222 | ||||
Return On Asset | 0.0473 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.18 % | ||||
Current Valuation | 11.34 B | ||||
Shares Outstanding | 113.74 M | ||||
Price To Earning | 73.16 X | ||||
Price To Book | 2.83 X | ||||
Price To Sales | 4.64 X | ||||
Revenue | 1.57 B | ||||
Gross Profit | 759.12 M | ||||
EBITDA | 310.13 M | ||||
Net Income | 122.87 M | ||||
Cash And Equivalents | 408.01 M | ||||
Cash Per Share | 4.10 X | ||||
Total Debt | 520.4 M | ||||
Debt To Equity | 0 % | ||||
Current Ratio | 6.10 X | ||||
Book Value Per Share | 29.94 X | ||||
Cash Flow From Operations | 243.5 M | ||||
Earnings Per Share | 0.62 X | ||||
Market Capitalization | 11.5 B | ||||
Total Asset | 5.09 B | ||||
Retained Earnings | 1.14 B | ||||
Working Capital | 1.52 B | ||||
Current Asset | 544.8 M | ||||
Current Liabilities | 82.69 M | ||||
About Globus Medical Performance
By analyzing Globus Medical's fundamental ratios, stakeholders can gain valuable insights into Globus Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Globus Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Globus Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 564.73 | 592.96 | |
Return On Tangible Assets | 0.05 | 0.04 | |
Return On Capital Employed | 0.03 | 0.03 | |
Return On Assets | 0.02 | 0.02 | |
Return On Equity | 0.03 | 0.03 |
Things to note about Globus Medical performance evaluation
Checking the ongoing alerts about Globus Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Globus Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Over 82.0% of the company shares are owned by institutional investors | |
Latest headline from investing.com: Globus Medicals SWOT analysis stock soars on merger synergies, FDA hurdles loom |
- Analyzing Globus Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Globus Medical's stock is overvalued or undervalued compared to its peers.
- Examining Globus Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Globus Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Globus Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Globus Medical's stock. These opinions can provide insight into Globus Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |